author-photo

Edvardas Kaminskas

Center for Drug Evaluation and Research

11

Papers

1480

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tank.

2016 American Heart Journal
Show All
- Source
- Cite
- Save
Citations (28)
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia

2015 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (78)
FDA Approval: Idelalisib Monotherapy for the Treatment of Patients with Follicular Lymphoma and Small Lymphocytic Lymphoma

2015 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (94)
FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma

2015 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (191)
U.S. Food and Drug Administration Approval: Obinutuzumab in Combination with Chlorambucil for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia

2014 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (32)
U.S. Food and Drug Administration Approval Summary: Omacetaxine Mepesuccinate as Treatment for Chronic Myeloid Leukemia

2014 Oncologist
Show All
- Source
- Cite
- Save
Citations (53)
U.S. Food and Drug Administration Approval: Ruxolitinib for the Treatment of Patients with Intermediate and High-Risk Myelofibrosis

2012 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (90)
Ixabepilone in Combination with Capecitabine and as Monotherapy for Treatment of Advanced Breast Cancer Refractory to Previous Chemotherapies

2008 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (55)
Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate

2008 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (203)
Approval Summary: Azacitidine for Treatment of Myelodysplastic Syndrome Subtypes

2005 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (323)